Daily FNArena News

FNArena is one of few remaining truly independent providers of financial markets analysis, financial commentary and business news in Australia. Our Daily Financial News is not based on ASX lodgements or corporate press releases, but more so on updated views, insights and responses from stockbrokers and other experts. FNArena is not aligned with any financial institution, hence the moniker “independent”. We have a long history of publishing out-of-consensus views and market analysis. Our quest is not to be bullish or bearish, but to correctly assess future trends.

Australia | Book Reviews | Commodities | ESG Focus | FYI | International | Small Caps | Technicals | Treasure Chest |

Previous Stories

FNArena Corporate Results Monitor – 03-02-2021

Feb 03 2021 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Quality Clientele To Underpin Fineos

Feb 03 2021 - Australia

As 2020 ended, opposing forces were in play for insurance software provider Fineos Corp, while a quality global customer base is ultimately expected to underpin growth

Six Top 100 Stocks With 20 Percent Upside

Feb 02 2021 - FYI

Peter Switzer of the Switzer Report highlights six large cap stocks analyst consensus suggests offer 20% plus share price upside.

Recovery Still On Offer For Worley

Feb 02 2021 - Australia

The market has pared the short-term outlook for Worley after a surprise slump in first half revenue, although recovery potential is not lost

ASX200: Volatility A Cause For Concern

Feb 02 2021 - Technicals

Michael Gable of Fairmont Equities suggests the trend for the ASX200 remains up, but recent volatility presents the risk of a short term pullback

ESG Focus: Trigger Fingers Out For 2021 But For Which Classes?

Feb 02 2021 - ESG Focus

ESG funds ballooned in 2020, as investors sought safe havens from covid and the Saudi-Russia oil price war but 2021 is a different story

Growth For ResMed Despite Challenges

Feb 01 2021 - Australia

Growth in masks and accessories has prevailed for ResMed despite pandemic-induced restrictions, although cycling the surge in ventilator sales from early 2020 will be a challenge

BlueScope On Top Of The Housing Boom

Feb 01 2021 - Australia

Sales from the mills of BlueScope Steel are going gangbusters, auguring well for the outlook over FY21. Are there any clouds on the horizon?

FNArena Corporate Results Monitor – 01-02-2021

Feb 01 2021 - Australia

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

Are Chinese Shares A Unique Opportunity? Part I

Jan 29 2021 - International

China plays a vital role in the world economy, yet the West is taking measures to curtail its rise. Part 1 in a series of 2

« Older Stories
Newer Stories »

Analyse The Market From A Different Angle

ICARUS SIGNAL

Consensus price targets can be a useful tool to assess whether stocks are running too hard, or falling too deeply.
R-FACTOR

Relative ranking of ASX200 stocks in accordance with consensus forecasts for growth, valuation and yield.
SENTIMENT INDICATOR

Evaluate circa 400 ASX-listed stocks on the basis of High/Low expert sentiment, forecast dividend yield.

Latest News

1
TechnologyOne’s SaaS Transformation ‘Complete’

Oct 07 2025 - Australia
2
Stock Market in September Republish

Oct 06 2025 - International
3
Stock Market in September

Oct 06 2025 - International
4
TechnologyOne Story by Novi

Oct 06 2025 - International
5
Geopolitical Hedging Drives Investor Confidence in CommBank

Jun 12 2025 - General

Most Popular